Company Overview
- Website
- asieris.cn
- Employees
- 49
- Founded in
- 2010
- Industry
- Materials/Manufacturing
Financials & Stats
Revenue
$100B
Recent News & Media
Bladder Cancer Clinical Trials, Key Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | UroGen Pharma Ltd., Asieris Pharmaceuticals, G1 Therapeutics, Inc., Linto
- Jul 2, 2025
- theglobeandmail.com
Asieris Pharmaceuticals Releases 2024 Annual Report, with Revenue Exceeding RMB 200M in 1st Year of Commercialization and Innovative Portfolio Accelerating Toward Launch
- Apr 18, 2025
- prnewswire.com
China’s Asieris Strikes Deal With US’ CDC to Supply Novel Drug for Free-living Ameba Infections
- Jan 7, 2025
- yicaiglobal.com
Asieris & CDC Sign Investigational Drug Supply Agreement for APL-1202
- Jan 6, 2025
- contractpharma.com
Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program
- Jan 6, 2025
- prnewswire.com
PHO: Photocure Partner Asieris announces Marketing Approval by the National Medical Products Administration for Hexvix in China
- Nov 5, 2024
- finansavisen.no
Companies Similar to Asieris Pharmaceuticals
Analyze industry trends and opportunities by examining competitors and companies comparable to Asieris Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 100M | 456 | Newton, MA | ||
| 100M | 240 | New York, NY | 2014 | |
| 100M | 18 | Tallahassee, FL | 1996 | |
| 100M | 168 | Jacksonville, FL | 1927 | |
| 100M | 11 | New York, NY | 2011 |